Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Journal of Gastroenterology
Literature
1.
2.
Lee YH, Kim SU, Song K, et al. Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: Nationwide surveys (KNHANES 2008-2011). Hepatology. 2016;63:776–86.CrossRefPubMed
3.
Koo BK, Kim D, Joo SK, et al. Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis. J Hepatol. 2017;66:123–31.CrossRefPubMed
4.
Metadata
Title
Sarcopenia definition in patients with NAFLD
Author
Tao-Chun Peng
Publication date
01-03-2019
Publisher
Springer Japan
Published in
Journal of Gastroenterology / Issue 3/2019
Print ISSN: 0944-1174
Electronic ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-018-1496-5

Other articles of this Issue 3/2019

Journal of Gastroenterology 3/2019 Go to the issue

Original Article—Liver, Pancreas, and Biliary Tract

Clinical significance of hepatic steatosis according to coronary plaque morphology: assessment using controlled attenuation parameter

Original Article—Liver, Pancreas, and Biliary Tract

Real-world efficacy of glecaprevir plus pibrentasvir for chronic hepatitis C patient with previous direct-acting antiviral therapy failures

Review

Antimicrobial proteins: intestinal guards to protect against liver disease

Original Article—Alimentary Tract

The role of small intestinal bacterial overgrowth in cystic fibrosis: a randomized case-controlled clinical trial with rifaximin

Original Article—Alimentary Tract

Capsule endoscopy findings for the diagnosis of Crohn’s disease: a nationwide case–control study

Review

Alcoholic and non-alcoholic steatohepatitis: global perspective and emerging science

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits